Before the market opened on September 13, RegenXbio (NASDAQ:RGNX) and AbbVie (NYSE:ABBV) announced a partnership to develop and commercialize RGX-314, [...]
Pliant Therapeutics (NASDAQ:PLRX) reported positive results on September 7 in a phase IIa PET imaging trial for PLN-74809, the company’s [...]
Based the strong run up in shares of Impel NeuroPharma (NASDAQ:IMPL) in the last six weeks, SanaCurrents is closing its coverage and [...]
AtriCure, Inc. (NASDAQ:ATRC) said earlier this month its US sales team was executing on the commercial launch of its EPi-Sense [...]
Maravai LifeSciences (NASDAQ:MRVI) plans to announce its second quarter 2021 financial and operating results after the market closes on Tuesday, [...]
Annexon, Inc. (NASDAQ:ANNX) and AtriCure, Inc. (NASDAQ:ATRC) recently delayed the reporting of their respective catalysts until the second half of [...]
Arcus Biosciences, Inc., (NASDAQ:RCUS) reported the first interim analysis of the three-arm, randomized, phase II Arc-7 cancer study after the [...]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) said prior to the opening of the market on June 21 that its Saturn-1 Phase IIb/III [...]
